The recent conclusion of the Australia–EU Free Trade Agreement makes it critical for Australian practitioners to understand how European patent practice differs in substance and strategy. Gain a clear understanding of the fundamental differences between Australian and European patent systems, develop practical insight into key legal requirements and identify common traps for Australian applicants. Develop valuable awareness of the Unified Patent Court and its implications for enforcement and risk management, enabling more confident, strategic advice for clients with European commercial interests.
Thursday, 4 June 2026
Description
Attend and earn 1 CPE Hour in Patents
This program is applicable to practitioners from all States & Territories
12.00pm to 1.00pm An Australian Perspective on European Patent Practice
- Effect of the free trade agreement
- Understanding the fundamental differences
- Comparing key legal requirements
- Traps for Australian applicants
- The Unified Patent Court
Presented by Paul Whenman, Consulting Partner, FB Rice
Presenters
Paul Whenman, Consulting Partner, FB Rice
Paul Whenman is a consulting partner in our Sydney chemistry team. As a qualified patent attorney, Paul has had a distinguished career with the firm as managing partner for 10 years. Throughout his 40 years’ practice in FB Rice, he has gained significant experience in chemically related patents, including pharmaceuticals, animal health products, food technology, personal care products and alloys. Indeed, a significant component of Paul’s practice relates to the interplay between the regulation of pharmaceuticals and animal health products and patent systems. Of particular relevance is the patent term extension regime in Australia and foreign jurisdictions. Commensurate with his deep understanding of patent law and chemical technologies, Paul regularly publishes articles offering opinions and insights into a variety of topics. With a significant international reputation, Paul has been recognized as an IP Star/Notable Practitioner for patent prosecution in Managing Intellectual Property for many years, most recently in 2025. He is also listed by IAM as a Strategy 300 IP strategist 2022. As the importance of South East Asian markets have grown, Paul maintains a strong focus on IP developments in those countries as means of providing the best experience for clients. Within FB Rice, Paul has trained and mentored many attorneys. An important component of this training has been a focus on the ethical considerations relevant for attorneys and the conduct of an attorneys practice. The experience gained as managing partner and subsequently as life sciences practice group leader combined with the technical and legal foundations as a practicing attorney, have provided Paul with a significant depth of knowledge of relevance to all patent and trade mark attorneys.
